# Marine-Lenhart syndrome combined with papillary thyroid carcinoma: a case report

**Authors:** Yong Zhuang, Wanrong Lin, Qingyan Cai, Huibin Huang

PMC · DOI: 10.3389/fendo.2026.1771308 · Frontiers in Endocrinology · 2026-02-23

## TL;DR

A rare case of Marine-Lenhart syndrome combined with papillary thyroid carcinoma is reported, highlighting the need to consider malignancy even in hyperfunctioning thyroid nodules.

## Contribution

This case report presents a rare combination of Marine-Lenhart syndrome and papillary thyroid carcinoma, emphasizing the importance of thorough evaluation.

## Key findings

- Marine-Lenhart syndrome was combined with a malignant thyroid nodule and papillary thyroid carcinoma.
- A hot nodule on 99m TcO4 scan was confirmed as malignant through biopsy and surgery.
- The case underscores the need to consider thyroid malignancy even in hyperfunctioning nodules associated with Graves’ disease.

## Abstract

Marine-Lenhart syndrome is a rare clinical condition, and most thyroid nodules combined with Marine-Lenhart syndrome are benign nodules. In this case, Marine-Lenhart syndrome was combined with a malignant nodule and a papillary thyroid carcinoma, which is even rarer.

Case presentation: We report a case of Marine-Lenhart syndrome in which the 99m TcO4 scan indicated a “hot nodule” in the thyroid. However, due to the patient’s thyroid ultrasound revealing a TI-RADS 4a categorized nodule, we performed a thyroid fine-needle aspiration biopsy followed by subsequent thyroid lobectomy with isthmusectomy. Both the results of pathological analysis confirmed the presence of papillary thyroid carcinoma.

After confirming the presence of Graves’ disease, it is still essential to consider the possibility of thyroid hyperfunctioning adenoma, namely Marine-Lenhart syndrome. Although most thyroid nodules associated with Marine-Lenhart syndrome are benign and often present as “hot nodules,” it is crucial not to disregard the small probability of thyroid malignancy in such cases.

## Linked entities

- **Chemicals:** 99m TcO4 (PubChem CID 23689036)
- **Diseases:** papillary thyroid carcinoma (MONDO:0005075), Graves’ disease (MONDO:0005364)

## Full-text entities

- **Genes:** TSHR (thyroid stimulating hormone receptor) [NCBI Gene 7253] {aka CHNG1, LGR3, hTSHR-I}, TPO (thyroid peroxidase) [NCBI Gene 7173] {aka MSA, TDH2A, TPX}, TG (thyroglobulin) [NCBI Gene 7038] {aka AITD3, TGN}
- **Diseases:** hoarseness (MESH:D006685), sinus tachycardia (MESH:D013616), thyroid hyperfunctioning adenoma (MESH:C566386), palpitations (MESH:D006331), nodular goiter (MESH:D006044), weight loss (MESH:D015431), metastasis (MESH:D009362), thyroid cancer (MESH:D013964), follicular carcinomas (MESH:D018263), Graves' disease (MESH:D006111), Papillary thyroid carcinoma (MESH:D000077273), adenoma (MESH:D000236), hyperthyroidism (MESH:D006980), shortness of breath (MESH:D004417), cancer metastasis (MESH:D009369), calcifications (MESH:D002114), thyroid nodule (MESH:D016606), Marine-Lenhart syndrome (MESH:D013577)
- **Chemicals:** triiodothyronine (MESH:D014284), radioiodine (MESH:C000614965), propranolol (MESH:D011433), FT3 (-), levothyroxine (MESH:D013974), Propylthiouracil (MESH:D011441), 99mTcO4 (MESH:D013670)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12967926/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12967926/full.md

## References

10 references — full list in the complete paper: https://tomesphere.com/paper/PMC12967926/full.md

---
Source: https://tomesphere.com/paper/PMC12967926